Silver Spring, Maryland–(ENEWSPF)–November 23, 2015. The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. “Opdivo provides an important therapy option for patients with renal cell carcinoma,”[Read More…]
Health and Fitness
New Documents Reveal Major Flaws in Nation’s Food Safety Inspection System
Records obtained by Food & Water Watch show that food safety inspectors are overworked, and it’s threatening our nation’s food supply. Washington, D.C.—(ENEWSPF)–November 23, 2015. New documents released today by the national advocacy organization Food & Water Watch reveal that inspectors who work for USDA’s Food Safety and Inspection Service (FSIS)[Read More…]
Hillary Clinton Blasts Pfizer-Allergan Merger, Says Deal ‘Will Leave U.S. Taxpayers Holding the Bag’
Clinton: We cannot delay in cracking down on inversions that erode our tax base NEW YORK–(ENEWSPF)–November 23, 2015. Today, Hillary Clinton is expressing her deep concerns with the announced merger of Pfizer and Allergan, which would produce the world’s largest pharmaceutical company by allowing Pfizer to shift its corporate residence[Read More…]
Male and female Drinking Patterns Becoming More Alike in the US
Bethesda, Maryland–(ENEWSPF)–November 23, 2015. In the United States, and throughout the world, men drink more alcohol than women. But a recent analysis by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, indicates that longstanding differences between men and women in[Read More…]
Senators Announce Introduction of Bipartisan Bill to Expand Breastfeeding Protections at Work
WASHINGTON, DC –(ENEWSPF)–November 20, 2015. Today, Oregon’s Senators Ron Wyden and Jeff Merkley and Sen. Lisa Murkowski (R-AK), joined by Sens. Charles E. Schumer (D-NY), Edward J. Markey (D-MA), Kirsten Gillibrand (D-NY), Elizabeth Warren (D-MA), and Al Franken (D-MN), announced the introduction of the Supporting Working Moms Act of[Read More…]
FTC Sends Refund Checks Totaling More Than $250,000 To Consumers Who Bought Lipidryl Weight Loss Supplement
Checks Are Being Mailed Nationwide This Week Washington, DC–(ENEWSPF)–November 20, 2015. The Federal Trade Commission is mailing 1,596 refund checks totaling $250,485 to consumers nationwide who bought the dietary supplement Lipidryl for purported weight loss. These are legitimate refund checks, and must be cashed within 60 days of the date[Read More…]
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Silver Spring, Maryland–(ENEWSPF)–November 20, 2015. Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy. Multiple myeloma is a form of blood cancer that occurs in infection-fighting plasma[Read More…]
Senator Merkley Responds to FDA Approval of Genetically-Modified Salmon
WASHINGTON, D.C. –(ENEWSPF)–November 19, 2015. Oregon’s Senator Jeff Merkley released the following statement after the FDA announced their approval of genetically-modified salmon for human consumption: “The United States has never approved a genetically-modified animal for human consumption before, and for good reason. Many Americans are troubled by how many of[Read More…]
Study: Marijuana Consumers Less Likely To Suffer From Metabolic Syndrome
Miami, FL–(ENEWSPF)–November 19, 2015. Those who consume cannabis are 50 percent less likely to suffer from metabolic syndrome as compared to those who do not, according to findings published online ahead of print in The American Journal of Medicine. Metabolic syndrome is a group of risk factors, including high blood[Read More…]
Study: Cannabinoids Are Safe, Effective For Pain Treatment
Halifax, Canada–(ENEWSPF)–November 19, 2015. Cannabinoids are safe and effective in the treatment of chronic pain, according to the results of a systematic review of randomized controlled trials published in the Journal of Neuroimmune Pharmacology. Investigators from Dalhousie University in Halifax, Nova Scotia and McGill University in Montreal evaluated the results[Read More…]
